{"id":45415,"date":"2022-06-23T13:01:55","date_gmt":"2022-06-23T11:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/"},"modified":"2022-06-23T13:01:55","modified_gmt":"2022-06-23T11:01:55","slug":"hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/","title":{"rendered":"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery"},"content":{"rendered":"<div>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kins.com%2F&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=Kins&amp;index=1&amp;md5=2f722f736a77f6a20ddd6cafe7567ae0\" rel=\"nofollow noopener\" shape=\"rect\">Kins<\/a>, a digital-first, hybrid care physical therapy practice, announced today $4 million in new seed funding, raising $7.2M to-date, as well as expansion into Massachusetts. Kins\u2019 recent funding round was led by W Health Ventures, which invests in and scales early-stage healthcare companies that are reinventing care delivery. Other notable angels in the medical field also participated, joining existing shareholder Redesign Health. Kins will use this new financing to further develop the company&#8217;s hybrid model of in-home and virtual care delivery and expand into new markets.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/4\/1632147845228.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg\"><\/a><\/p>\n<p>\n\u201cAt W Health we believe in transforming health care delivery &#8211; Kins is doing exactly that for the antiquated outpatient Physical Therapy industry,\u201d said Dr. Pankaj Jethwani, Executive Vice President at W Health. \u201cWe\u2019re impressed by the team, the mission and the results to date. As a health tech investor we look forward to the impact Kins will have in the years ahead.\u201d\n<\/p>\n<p>\nToday\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fblog.marketresearch.com%2Fu.s.-physical-therapy-clinics-constitute-a-growing-34-billion-industry%23%3A~%3Atext%3D&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=%2434+billion+dollar&amp;index=2&amp;md5=8c401ac96068bbfdce7ab9398c95a23b\" rel=\"nofollow noopener\" shape=\"rect\">$34 billion dollar<\/a> outpatient physical therapy industry is inconvenient, outdated, and is burning out therapists. This clinic-centric experience contributes to a <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.webpt.com%2Fblog%2Fexpectation-vs-reality-why-patients-really-drop-out-of-therapy%2F&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=70%25+drop+out+rate&amp;index=3&amp;md5=950bcfe2b743633697a89bd869667124\" rel=\"nofollow noopener\" shape=\"rect\">70% drop out rate<\/a>, a clinical outcomes improvement rate of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cerortho.com%2Fdownloads%2Ffiles%2FPRO_as_Performance%2520Measures%2520in%2520PT.pdf&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=only+15%25&amp;index=4&amp;md5=6460b048ece75a14bec9d544ce0a67d5\" rel=\"nofollow noopener\" shape=\"rect\">only 15%<\/a> per patient, and a therapist turnover rate as high as 40%. Kins was founded on the belief that a 1-on-1 patient-centric experience will flip these metrics for patients and therapists alike.\n<\/p>\n<p>\n\u201cOur mission at Kins is simply to help people get back to doing what they love,\u201d stated Dan Smith, CEO of Kins. \u201cBy adopting a patient-centric approach, rather than a clinic-centric approach, we are delivering experiences and outcomes multiples better than industry averages. We see patients where they are &#8211; in their homes, in person, via tele-health, in between visits, whatever works best for them and their goals. Our hybrid model helps provider groups and health systems grow their footprint, helps payers lower costs, and most importantly, helps our patients recover more efficiently.\u201d\n<\/p>\n<p>\nKins has achieved strong traction since its launch last year, experiencing 30% month-over-month growth, recent expansion to Massachusetts, and patient outcomes including:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n4.9 out of 5 star patient satisfaction rating\n<\/li>\n<li>\n68% retention to care plan\n<\/li>\n<li>\n71% clinical improvement per patient\n<\/li>\n<\/ul>\n<p>\n\u201cKins\u2019 hybrid care model not only modernizes physical therapy treatment for patients but also for therapists,\u201d stated Nadine Booysen, Chief Clinical Officer of Kins. \u201cWe believe physical therapists will lead the charge in the future of conservative care in musculoskeletal health. Kins provides therapists autonomy and flexibility for a better work life balance and to provide high-value care while having the time to build relationships with their patients.\u201d\n<\/p>\n<p>\nKins launched in New York in September 2021 with partnerships including Aetna, Cigna and UnitedHealthCare. They have launched in Boston, adding Blue Cross Blue Shield, Harvard Pilgrim and Optum Care. Kins is hiring and partnering in New York, Massachusetts, and additional markets in the months ahead. For inquiry, contact <a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;p&#114;&#x65;&#115;&#x73;&#64;&#107;&#x69;n&#x73;&#46;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x6b;&#x69;&#x6e;&#x73;&#x2e;&#99;&#111;&#109;<\/a>\n<\/p>\n<p>\n<b>About Kins<\/b>\n<\/p>\n<p>\nKins is a physical therapy program for active people seeking personal connection and modern convenience. Offering a hybrid model of in-person and virtual care, Kins enables therapists and patients to collaborate in creating a course of care designed around the patient&#8217;s needs. Kins was founded in 2021 at Redesign Health. For more information about Kins, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kins.com%2F&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=Kins.com&amp;index=5&amp;md5=859ea3b48b730fd1cb731dd2a12abc7b\" rel=\"nofollow noopener\" shape=\"rect\">Kins.com<\/a>.\n<\/p>\n<p>\n<b>About W Health<\/b>\n<\/p>\n<p>\nW Health Ventures is a Boston-based venture capital firm focused on helping entrepreneurs build the future of healthcare delivery. Founded by serial technology entrepreneur, investor, and philanthropist Sunil Wadhwani, W Health invests in and grows tech-enabled early-stage healthcare companies that are disrupting care delivery in the US and India. The W Health team and advisory network comprise seasoned investors, physician leaders, technology experts, and healthcare operators in the US and India. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.whealthventures.com&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=whealthventures.com&amp;index=6&amp;md5=d6ba7db83e4778a81f45cedf26c482db\" rel=\"nofollow noopener\" shape=\"rect\">whealthventures.com<\/a>\n<\/p>\n<p>\n<b>About Redesign Health<\/b>\n<\/p>\n<p>\nRedesign Health is a company that powers innovation in healthcare by developing technologies, tools, and insights that lower the barriers to change across the industry. Since 2018, exceptional founders have built over two dozen companies at Redesign Health, impacting more than ten million lives across many aspects of the healthcare ecosystem including cancer care, teleaudiology, COVID-19 testing, metabolic health and more. To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fredesignhealth.com%2F&amp;esheet=52758809&amp;newsitemid=20220623005079&amp;lan=en-US&amp;anchor=redesignhealth.com&amp;index=7&amp;md5=b98acb1947d200fa3014402e7bfdb461\" rel=\"nofollow noopener\" shape=\"rect\">redesignhealth.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBethany Dufresne<br \/>\n<br \/>Director of Product Communications, Redesign Health<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#111;&#x3a;&#98;&#x65;t&#x68;a&#110;&#x79;&#46;&#x64;u&#x66;&#x72;&#101;&#x73;n&#x65;&#64;&#114;&#x65;&#100;&#x65;s&#x69;g&#110;&#x68;&#101;&#x61;l&#116;&#x68;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x62;&#x65;&#x74;&#x68;&#x61;&#110;&#121;&#46;&#100;ufr&#x65;&#x73;&#x6e;&#x65;&#x40;&#x72;&#101;&#100;&#101;sig&#x6e;&#x68;&#x65;&#x61;&#x6c;&#x74;&#104;&#46;&#99;&#111;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;Kins, a digital-first, hybrid care physical therapy practice, announced today $4 million in new seed funding, raising $7.2M to-date, as well as expansion into Massachusetts. Kins\u2019 recent funding round was led by W Health Ventures, which invests in and scales early-stage healthcare companies that are reinventing care delivery. Other notable angels in the medical &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45415","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON&#8211;(BUSINESS WIRE)&#8211;Kins, a digital-first, hybrid care physical therapy practice, announced today $4 million in new seed funding, raising $7.2M to-date, as well as expansion into Massachusetts. Kins\u2019 recent funding round was led by W Health Ventures, which invests in and scales early-stage healthcare companies that are reinventing care delivery. Other notable angels in the medical ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-23T11:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery\",\"datePublished\":\"2022-06-23T11:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/\"},\"wordCount\":702,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220623005079\\\/en\\\/1494116\\\/21\\\/1632147845228.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/\",\"name\":\"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220623005079\\\/en\\\/1494116\\\/21\\\/1632147845228.jpg\",\"datePublished\":\"2022-06-23T11:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220623005079\\\/en\\\/1494116\\\/21\\\/1632147845228.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220623005079\\\/en\\\/1494116\\\/21\\\/1632147845228.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/","og_locale":"en_US","og_type":"article","og_title":"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery - Pharma Trend","og_description":"BOSTON&#8211;(BUSINESS WIRE)&#8211;Kins, a digital-first, hybrid care physical therapy practice, announced today $4 million in new seed funding, raising $7.2M to-date, as well as expansion into Massachusetts. Kins\u2019 recent funding round was led by W Health Ventures, which invests in and scales early-stage healthcare companies that are reinventing care delivery. Other notable angels in the medical ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-23T11:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery","datePublished":"2022-06-23T11:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/"},"wordCount":702,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/","url":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/","name":"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg","datePublished":"2022-06-23T11:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220623005079\/en\/1494116\/21\/1632147845228.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hybrid-care-physical-therapy-platform-kins-announces-7-2m-in-total-seed-funding-to-accelerate-innovation-in-care-delivery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hybrid-care Physical Therapy Platform Kins Announces $7.2M in Total Seed Funding to Accelerate Innovation in Care Delivery"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45415"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45415\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}